"fda" - Google News

RFK ally confirms she was fired by FDA: ‘I learned so much and leave with no regrets’ - Fortune

Sat, 16 May 2026 14:22:00 GMT

RFK ally confirms she was fired by FDA: ‘I learned so much and leave with no regrets’ Fortune

FDA Revamp Begins With the Departure of a Marty Makary Ally - Bloomberg.com

Sat, 16 May 2026 01:53:00 GMT

FDA Revamp Begins With the Departure of a Marty Makary Ally Bloomberg.com

FDA’s top drug regulator ousted amid agency upheaval - The Hill

Mon, 18 May 2026 15:31:00 GMT

FDA’s top drug regulator ousted amid agency upheaval The Hill

FDA chief, head of vaccines and head of drug evaluation roles all under temporary leadership - CNBC

Mon, 18 May 2026 12:54:19 GMT

FDA chief, head of vaccines and head of drug evaluation roles all under temporary leadership CNBC

Ice cream recall: These organic flavors may have metal fragments, FDA says - Houston Chronicle

Sun, 17 May 2026 21:25:45 GMT

Ice cream recall: These organic flavors may have metal fragments, FDA says Houston Chronicle

FDA drops guardrails on vaping industry in major Trump pivot - WANE 15

Mon, 18 May 2026 11:26:25 GMT

FDA drops guardrails on vaping industry in major Trump pivot WANE 15

FDA drug center head fired after commissioner's exit, replaced by Davis - Reuters

Sat, 16 May 2026 17:13:05 GMT

FDA drug center head fired after commissioner's exit, replaced by Davis Reuters

Top Drug Regulator Is Fired From the F.D.A. - The New York Times

Sat, 16 May 2026 00:31:49 GMT

Top Drug Regulator Is Fired From the F.D.A. The New York Times

FDA turmoil deepens as top drug chief departs claiming she was fired - The Guardian

Sat, 16 May 2026 04:26:00 GMT

FDA turmoil deepens as top drug chief departs claiming she was fired The Guardian

FDA Approves First Golimumab Biosimilars to Treat RA and UC - Medscape

Mon, 18 May 2026 10:50:55 GMT

FDA Approves First Golimumab Biosimilars to Treat RA and UC Medscape

Prasad ally Szarama exits CBER after 3 weeks as FDA cleanout continues - BioSpace

Mon, 18 May 2026 12:07:38 GMT

Prasad ally Szarama exits CBER after 3 weeks as FDA cleanout continues BioSpace

FDA Approves Fam-Trastuzumab Deruxtecan-nxki Indications in HER2 Positive Early Breast Cancer - The ASCO Post

Mon, 18 May 2026 14:07:51 GMT

FDA Approves Fam-Trastuzumab Deruxtecan-nxki Indications in HER2 Positive Early Breast Cancer The ASCO Post

Investigations of Foodborne Illness Outbreaks - fda.gov

Wed, 13 May 2026 14:00:00 GMT

Investigations of Foodborne Illness Outbreaks fda.gov

FDA Approves Atezolizumab for Muscle-Invasive Bladder Cancer - Oncology News Central

Mon, 18 May 2026 10:45:21 GMT

FDA Approves Atezolizumab for Muscle-Invasive Bladder Cancer Oncology News Central

FDA Approves Baxdrostat for Uncontrolled Hypertension on Background Therapy - HCPLive

Mon, 18 May 2026 13:49:09 GMT

FDA Approves Baxdrostat for Uncontrolled Hypertension on Background Therapy HCPLive

FDA Approves Enhertu for 2 New Indications for Patients With HER2+ Early Breast Cancer - AJMC

Mon, 18 May 2026 14:16:55 GMT

FDA Approves Enhertu for 2 New Indications for Patients With HER2+ Early Breast Cancer AJMC

Flavored vapes led to a major shake-up at the FDA – 3 health policy analysts explain the science behind the controversial products - The Conversation

Mon, 18 May 2026 12:21:18 GMT

Flavored vapes led to a major shake-up at the FDA – 3 health policy analysts explain the science behind the controversial products The Conversation

FDA Approves Baxdrostat for Inadequately Controlled Hypertension - TCTMD.com

Mon, 18 May 2026 14:13:41 GMT

FDA Approves Baxdrostat for Inadequately Controlled Hypertension TCTMD.com

U.S. FDA Accepts Viatris New Drug Application for Fast-Acting Meloxicam for the Treatment of Moderate-to-Severe Acute Pain - PR Newswire

Mon, 18 May 2026 12:00:00 GMT

U.S. FDA Accepts Viatris New Drug Application for Fast-Acting Meloxicam for the Treatment of Moderate-to-Severe Acute Pain PR Newswire

Marty Makary misunderstood something fundamental about the FDA - statnews.com

Sat, 16 May 2026 11:02:53 GMT

Marty Makary misunderstood something fundamental about the FDA statnews.com

FDA Expands T-DXd With 2 New Indications in HER2-Positive Early Breast Cancer - Pharmacy Times

Mon, 18 May 2026 15:36:14 GMT

FDA Expands T-DXd With 2 New Indications in HER2-Positive Early Breast Cancer Pharmacy Times

FDA Approves T-DXd in 2 Indications for HER2+ Early Breast Cancer - CancerNetwork

Mon, 18 May 2026 13:37:19 GMT

FDA Approves T-DXd in 2 Indications for HER2+ Early Breast Cancer CancerNetwork

FDA names safety vet acting head of food - Food Dive

Mon, 18 May 2026 15:02:38 GMT

FDA names safety vet acting head of food Food Dive

FDA shuffles top drug, biologics leaders in latest shakeup - CNBC

Sat, 16 May 2026 01:15:00 GMT

FDA shuffles top drug, biologics leaders in latest shakeup CNBC

How Pharma is Adjusting Strategies for Changing Dynamics at FDA - Pharmaceutical Executive

Mon, 18 May 2026 10:04:48 GMT

How Pharma is Adjusting Strategies for Changing Dynamics at FDA Pharmaceutical Executive

FDA Approves First Early-Stage Breast Cancer Indications for Trastuzumab Deruxtecan - Oncology News Central

Mon, 18 May 2026 10:29:36 GMT

FDA Approves First Early-Stage Breast Cancer Indications for Trastuzumab Deruxtecan Oncology News Central

Tracking Food Industry Pledges to Remove Petroleum Based Food Dyes - fda.gov

Tue, 12 May 2026 10:47:00 GMT

Tracking Food Industry Pledges to Remove Petroleum Based Food Dyes fda.gov

FDA Approves IMMGOLIS™ (golimumab-sldi) and IMMGOLIS INTRI™ (golimumab-sldi), First Biosimilars to Simponi® (golimumab) and Simponi Aria® (golimumab); Accord BioPharma to Lead U.S. Commercialization - PR Newswire

Mon, 18 May 2026 12:05:00 GMT

FDA Approves IMMGOLIS™ (golimumab-sldi) and IMMGOLIS INTRI™ (golimumab-sldi), First Biosimilars to Simponi® (golimumab) and Simponi Aria® (golimumab); Accord BioPharma to Lead U.S. Commercialization PR Newswire

FDA’s New Pilot Program and Real-Time Review of Clinical Data - Pharmaceutical Executive

Mon, 18 May 2026 10:04:48 GMT

FDA’s New Pilot Program and Real-Time Review of Clinical Data Pharmaceutical Executive

FDA Approves Immgolis and Immgolis Intri as First Biosimilars to Golimumab Reference Products for RA and UC - Pharmacy Times

Mon, 18 May 2026 15:36:13 GMT

FDA Approves Immgolis and Immgolis Intri as First Biosimilars to Golimumab Reference Products for RA and UC Pharmacy Times

FDA Makes Leadership Overhaul Following Commissioner Makary’s Departure: Report - Pharmaceutical Executive

Mon, 18 May 2026 15:37:40 GMT

FDA Makes Leadership Overhaul Following Commissioner Makary’s Departure: Report Pharmaceutical Executive

FDA Approves Baxdrostat for Uncontrolled Hypertension on Background Therapy - Patient Care Online

Mon, 18 May 2026 14:13:13 GMT

FDA Approves Baxdrostat for Uncontrolled Hypertension on Background Therapy Patient Care Online

Natera wins FDA approval for companion diagnostic - MedTech Dive

Mon, 18 May 2026 14:47:39 GMT

Natera wins FDA approval for companion diagnostic MedTech Dive

Bracco and ACIST Medical Systems Announce U.S. FDA Clearance of ACIST Pro™ Diagnostic System - PR Newswire

Mon, 18 May 2026 11:00:00 GMT

Bracco and ACIST Medical Systems Announce U.S. FDA Clearance of ACIST Pro™ Diagnostic System PR Newswire

AstraZeneca notches key FDA nod in hypertension, with an approval sweetener for Fasenra too - Fierce Pharma

Mon, 18 May 2026 15:23:39 GMT

AstraZeneca notches key FDA nod in hypertension, with an approval sweetener for Fasenra too Fierce Pharma

Daiichi, AstraZeneca’s Enhertu breaks into early breast cancer with dual FDA approvals - Fierce Pharma

Mon, 18 May 2026 14:52:01 GMT

Daiichi, AstraZeneca’s Enhertu breaks into early breast cancer with dual FDA approvals Fierce Pharma

FDA Clears Next-Generation Contrast Management System for Image-Guided Cardiovascular Procedures - diagnosticimaging.com

Mon, 18 May 2026 15:31:50 GMT

FDA Clears Next-Generation Contrast Management System for Image-Guided Cardiovascular Procedures diagnosticimaging.com

FDA Approves Baxdrostat for Uncontrolled Hypertension in First-in-Class Entry - Pharmaceutical Executive

Mon, 18 May 2026 15:12:40 GMT

FDA Approves Baxdrostat for Uncontrolled Hypertension in First-in-Class Entry Pharmaceutical Executive

FDA leadership shakeup widens following Makary’s departure - statnews.com

Fri, 15 May 2026 21:17:11 GMT

FDA leadership shakeup widens following Makary’s departure statnews.com

Sunscreen: How to Help Protect Your Skin from the Sun - fda.gov

Mon, 11 May 2026 00:00:00 GMT

Sunscreen: How to Help Protect Your Skin from the Sun fda.gov

Doctors concerned about impact of new FDA-approved flavored vapes - FOX13 Memphis

Mon, 18 May 2026 14:23:00 GMT

Doctors concerned about impact of new FDA-approved flavored vapes FOX13 Memphis

FDA Blocked Melanoma Drug as Confusion Reigned Under Makary - HealthLeaders Media

Mon, 18 May 2026 14:45:23 GMT

FDA Blocked Melanoma Drug as Confusion Reigned Under Makary HealthLeaders Media

FDA Expands Enhertu in Early HER2-Positive Breast Cancer - Pharmaceutical Executive

Mon, 18 May 2026 13:32:40 GMT

FDA Expands Enhertu in Early HER2-Positive Breast Cancer Pharmaceutical Executive

Makary’s successor faces tough task managing FDA amid budget cuts - ING THINK economic and financial analysis | ING THINK

Mon, 18 May 2026 07:00:12 GMT

Makary’s successor faces tough task managing FDA amid budget cuts ING THINK economic and financial analysis | ING THINK

Opinion: FDA alignment is critical to serving the rare disease community. AI can help - BioSpace

Mon, 18 May 2026 04:01:44 GMT

Opinion: FDA alignment is critical to serving the rare disease community. AI can help BioSpace

FDA Approves Baxdrostat as First Aldosterone Synthase Inhibitor for Hypertension - Drug Topics

Mon, 18 May 2026 13:44:32 GMT

FDA Approves Baxdrostat as First Aldosterone Synthase Inhibitor for Hypertension Drug Topics

FDA Commissioner Marty Makary Resigns After Trump Pressure - Dermatology Advisor

Mon, 18 May 2026 04:00:00 GMT

FDA Commissioner Marty Makary Resigns After Trump Pressure Dermatology Advisor

FDA leadership turmoil deepens after more exits - The Pharma Letter

Mon, 18 May 2026 09:36:37 GMT

FDA leadership turmoil deepens after more exits The Pharma Letter

NervGen Pharma Announces FDA Meeting Success, Advancements in NVG-291 Study, and Nasdaq Listing Update - Quiver Quantitative

Mon, 18 May 2026 11:20:00 GMT

NervGen Pharma Announces FDA Meeting Success, Advancements in NVG-291 Study, and Nasdaq Listing Update Quiver Quantitative

FDA Approves Label Expansion for Vyvgart, Vyvgart Hytrulo - Ophthalmology Advisor

Mon, 18 May 2026 04:00:00 GMT

FDA Approves Label Expansion for Vyvgart, Vyvgart Hytrulo Ophthalmology Advisor

Exclusive: FDA drug center head expected to leave after commissioner's exit, sources say - Reuters

Fri, 15 May 2026 16:28:58 GMT

Exclusive: FDA drug center head expected to leave after commissioner's exit, sources say Reuters

Infant Formula Homepage - fda.gov

Mon, 04 May 2026 07:00:00 GMT

Infant Formula Homepage fda.gov

New FDA approval for Genentech’s Tecentriq - The Pharma Letter

Mon, 18 May 2026 11:19:21 GMT

New FDA approval for Genentech’s Tecentriq The Pharma Letter

Second FDA executive departing organization in less than a week as top drug regulator claims she was fired - Fox News

Sat, 16 May 2026 18:37:14 GMT

Second FDA executive departing organization in less than a week as top drug regulator claims she was fired Fox News

FDA Expands Market Access, Authorizes New ENDS Products - fda.gov

Tue, 05 May 2026 07:00:00 GMT

FDA Expands Market Access, Authorizes New ENDS Products fda.gov

Ice cream sold at Texas grocers like Whole Foods, Sprouts may contain metal - MySA

Mon, 18 May 2026 14:46:53 GMT

Ice cream sold at Texas grocers like Whole Foods, Sprouts may contain metal MySA

FDA Approves Golimumab-Sldi as First Biosimilar for Simponi - Drug Topics

Mon, 18 May 2026 14:33:22 GMT

FDA Approves Golimumab-Sldi as First Biosimilar for Simponi Drug Topics

Donald Prater steps in as head of FDA Human Foods Program - NutraIngredients.com

Mon, 18 May 2026 13:38:54 GMT

Donald Prater steps in as head of FDA Human Foods Program NutraIngredients.com

Fight over fruit-flavored vapes pushed FDA chief to resign - NBC News

Thu, 14 May 2026 23:05:35 GMT

Fight over fruit-flavored vapes pushed FDA chief to resign NBC News

FDA Clears Golimumab Biosimilars - Conexiant

Mon, 18 May 2026 12:51:13 GMT

FDA Clears Golimumab Biosimilars Conexiant

Bio-Thera Solutions' Golimumab Biosimilars Receive FDA Approval as First Biosimilars to Simponi® and Simponi Aria®; Accord BioPharma to Commercialize IMMGOLIS™ (golimumab-sldi) and IMMGOLIS INTRI™ (golimumab-sldi) in the United States - May - BioSpace

Mon, 18 May 2026 14:41:10 GMT

Bio-Thera Solutions' Golimumab Biosimilars Receive FDA Approval as First Biosimilars to Simponi® and Simponi Aria®; Accord BioPharma to Commercialize IMMGOLIS™ (golimumab-sldi) and IMMGOLIS INTRI™ (golimumab-sldi) in the United States - May BioSpace

FDA accepts Viatris application for fast-acting meloxicam - Investing.com

Mon, 18 May 2026 12:26:34 GMT

FDA accepts Viatris application for fast-acting meloxicam Investing.com

FDA Approves Baxdrostat for Resistant Hypertension - Conexiant

Mon, 18 May 2026 13:36:32 GMT

FDA Approves Baxdrostat for Resistant Hypertension Conexiant

FDA investigator outlines issues with gummy manufacturing - NutraIngredients.com

Mon, 18 May 2026 13:31:58 GMT

FDA investigator outlines issues with gummy manufacturing NutraIngredients.com

Tracy Beth Høeg ousted from FDA in wider senior leadership shakeup - Yahoo

Mon, 18 May 2026 10:57:15 GMT

Tracy Beth Høeg ousted from FDA in wider senior leadership shakeup Yahoo

FDA Approves First Simponi Biosimilars in U.S. - Contract Pharma

Mon, 18 May 2026 13:32:22 GMT

FDA Approves First Simponi Biosimilars in U.S. Contract Pharma

Makary’s time atop FDA over, Diamantas named acting commissioner - Politico

Tue, 12 May 2026 18:38:29 GMT

Makary’s time atop FDA over, Diamantas named acting commissioner Politico

NYU Langone adopts new blood-circulation system after 30-patient trial - Stock Titan

Mon, 18 May 2026 11:30:00 GMT

NYU Langone adopts new blood-circulation system after 30-patient trial Stock Titan

New non-opioid pain drug from Viatris faces FDA decision on Dec. 27, 2026 - Stock Titan

Mon, 18 May 2026 12:00:00 GMT

New non-opioid pain drug from Viatris faces FDA decision on Dec. 27, 2026 Stock Titan

Opinion | What Is the FDA Hiding on Mifepristone? - WSJ

Sun, 17 May 2026 18:09:00 GMT

Opinion | What Is the FDA Hiding on Mifepristone? WSJ

AstraZeneca wins nod for blood pressure pill, opening new class of hypertension drugs - BioSpace

Mon, 18 May 2026 13:12:41 GMT

AstraZeneca wins nod for blood pressure pill, opening new class of hypertension drugs BioSpace

Commissioner's National Priority Voucher (CNPV) Pilot Program - fda.gov

Tue, 28 Apr 2026 07:00:00 GMT

Commissioner's National Priority Voucher (CNPV) Pilot Program fda.gov

FDA official who scrutinized COVID shots and antidepressants is out in latest shake-up - AP News

Sat, 16 May 2026 04:49:00 GMT

FDA official who scrutinized COVID shots and antidepressants is out in latest shake-up AP News

BeOne Medicines Wins Conditional FDA Nod For Cancer Drug In Rare Blood Cancer - Yahoo

Mon, 18 May 2026 11:01:02 GMT

BeOne Medicines Wins Conditional FDA Nod For Cancer Drug In Rare Blood Cancer Yahoo

Turn Therapeutics Appoints Physician-Scientist and Former FDA Commissioner, Dr. Stephen M. Hahn, as Executive Clinical and Regulatory Lead - Business Wire

Mon, 18 May 2026 12:05:00 GMT

Turn Therapeutics Appoints Physician-Scientist and Former FDA Commissioner, Dr. Stephen M. Hahn, as Executive Clinical and Regulatory Lead Business Wire

Environmental Contaminants in Food - fda.gov

Wed, 29 Apr 2026 07:00:00 GMT

Environmental Contaminants in Food fda.gov

FDA puts HYRNUO on Priority Review as first-line HER2 lung cancer option - Stock Titan

Mon, 18 May 2026 12:43:51 GMT

FDA puts HYRNUO on Priority Review as first-line HER2 lung cancer option Stock Titan

Marty Makary, Trump’s F.D.A. Commissioner, Resigns After Weeks of Pressure - The New York Times

Tue, 12 May 2026 17:30:32 GMT

Marty Makary, Trump’s F.D.A. Commissioner, Resigns After Weeks of Pressure The New York Times

FDA OKs all-oral therapy for AML patients not eligible for chemo - Rare Cancer News

Mon, 18 May 2026 14:43:27 GMT

FDA OKs all-oral therapy for AML patients not eligible for chemo Rare Cancer News

Nuvation Bio Sharpens IBTROZI Focus With Thermo Fisher And FDA Steps - Yahoo Finance

Mon, 18 May 2026 11:07:20 GMT

Nuvation Bio Sharpens IBTROZI Focus With Thermo Fisher And FDA Steps Yahoo Finance

Assessing GRAIL (GRAL) Valuation As Galleri Demand Grows And FDA And NHS Updates Progress - simplywall.st

Mon, 18 May 2026 14:38:44 GMT

Assessing GRAIL (GRAL) Valuation As Galleri Demand Grows And FDA And NHS Updates Progress simplywall.st

Across the Nutraverse: FDA leadership shake-up, NMN in the EU, TetraSOD in the USA - NutraIngredients.com

Mon, 18 May 2026 09:17:21 GMT

Across the Nutraverse: FDA leadership shake-up, NMN in the EU, TetraSOD in the USA NutraIngredients.com

U.S. FDA Grants Priority Review To Supplemental New Drug Application For Hyrnuo® (Sevabertinib) - TradingView

Mon, 18 May 2026 13:30:06 GMT

U.S. FDA Grants Priority Review To Supplemental New Drug Application For Hyrnuo® (Sevabertinib) TradingView

NTRA's Signatera CDx Wins FDA Nod in Muscle-Invasive Bladder Cancer - Zacks Investment Research

Mon, 18 May 2026 15:06:31 GMT

NTRA's Signatera CDx Wins FDA Nod in Muscle-Invasive Bladder Cancer Zacks Investment Research

FDA’s head of Drug Evaluation and Research fired after six months on the job - medwatch.com

Mon, 18 May 2026 06:25:00 GMT

FDA’s head of Drug Evaluation and Research fired after six months on the job medwatch.com

FDA Official Who Scrutinized COVID Shots, Antidepressants Is Out in Latest Shake-Up - MedPage Today

Sun, 17 May 2026 17:52:48 GMT

FDA Official Who Scrutinized COVID Shots, Antidepressants Is Out in Latest Shake-Up MedPage Today

FDA approves AstraZeneca's FASENRA for hypereosinophilic syndrome - Manufacturing Chemist

Mon, 18 May 2026 10:17:29 GMT

FDA approves AstraZeneca's FASENRA for hypereosinophilic syndrome Manufacturing Chemist

Datar Cancer Genetics erhält wegweisende FDA-Zulassung in den USA für CellDx-Tissue - umfassender Genomprofiling-Test für solide Tumoren - PR Newswire

Mon, 18 May 2026 04:18:00 GMT

Datar Cancer Genetics erhält wegweisende FDA-Zulassung in den USA für CellDx-Tissue - umfassender Genomprofiling-Test für solide Tumoren PR Newswire

FDA approves Enhertu for two HER2-positive early breast cancer indications - Yahoo

Mon, 18 May 2026 08:49:17 GMT

FDA approves Enhertu for two HER2-positive early breast cancer indications Yahoo

Marty Makary resigns as FDA commissioner following industry and White House backlash - CNBC

Tue, 12 May 2026 18:08:31 GMT

Marty Makary resigns as FDA commissioner following industry and White House backlash CNBC

AstraZeneca Gets FDA Nod for New Hypertension Drug Baxfendy - Zacks Investment Research

Mon, 18 May 2026 15:02:41 GMT

AstraZeneca Gets FDA Nod for New Hypertension Drug Baxfendy Zacks Investment Research

Signatera™ CDx Approved by the FDA as a Companion Diagnostic in Muscle-Invasive Bladder Cancer (MIBC) - BioSpace

Mon, 18 May 2026 01:17:27 GMT

Signatera™ CDx Approved by the FDA as a Companion Diagnostic in Muscle-Invasive Bladder Cancer (MIBC) BioSpace

Dr. Marty Makary is out as FDA commissioner - NBC News

Tue, 12 May 2026 17:20:00 GMT

Dr. Marty Makary is out as FDA commissioner NBC News

Artivion Closes Endospan Acquisition Following FDA Approval of NEXUS Aortic System - citybiz

Mon, 18 May 2026 12:27:35 GMT

Artivion Closes Endospan Acquisition Following FDA Approval of NEXUS Aortic System citybiz

Valar Labs Receives FDA Breakthrough Device Designation for Vesta Bladder Risk Stratify Dx - BioSpace

Mon, 18 May 2026 01:09:46 GMT

Valar Labs Receives FDA Breakthrough Device Designation for Vesta Bladder Risk Stratify Dx BioSpace

FDA Approves Genentech’s Tecentriq for Adjuvant Muscle-Invasive Bladder Cancer With ctDNA-Guided Treatment - BioSpace

Mon, 18 May 2026 01:17:24 GMT

FDA Approves Genentech’s Tecentriq for Adjuvant Muscle-Invasive Bladder Cancer With ctDNA-Guided Treatment BioSpace

‘Regulators were WELL AWARE…’: Whistleblower 'exposes' FDA, CDC over COVID-19 vaccine injuries - The Economic Times

Mon, 18 May 2026 11:10:50 GMT

‘Regulators were WELL AWARE…’: Whistleblower 'exposes' FDA, CDC over COVID-19 vaccine injuries The Economic Times

Roche's Tecentriq Wins FDA Nod for Label Expansion in Bladder Cancer - Zacks Investment Research

Mon, 18 May 2026 14:02:02 GMT

Roche's Tecentriq Wins FDA Nod for Label Expansion in Bladder Cancer Zacks Investment Research

Bayer - FDA Priority Review For Sevabertinib - TradingView

Mon, 18 May 2026 12:35:33 GMT

Bayer - FDA Priority Review For Sevabertinib TradingView

Trump's FDA chief is out after angering pharma CEOs, vaping lobbyists and anti-abortion activists - AP News

Tue, 12 May 2026 23:36:00 GMT

Trump's FDA chief is out after angering pharma CEOs, vaping lobbyists and anti-abortion activists AP News